NEMO mutation as a cause of familial occurrence of Behçet's disease in female patients

Clinical Genetics

Volumn 78, Issue 6, 2010, Pages 575-579

  Takada, H ^a   Nomura, A ^a   Ishimura, M ^a   Ichiyama, M ^a   Ohga, S ^a   Hara, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Beh et's disease; Nuclear factor B essential modulator Incontinentia pigmenti; X linked anhidrotic ectodermal dysplasia with immunodeficiency

Indexed keywords

I KAPPA B KINASE GAMMA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BEHCET DISEASE; CASE REPORT; CHILD; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HETEROZYGOTE; HLA TYPING; HOSPITAL ADMISSION; HUMAN; HYPOPIGMENTATION; INTESTINE MUCOSA; LEUKOCYTE COUNT; MOTHER; MOUTH MUCOSA; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; X CHROMOSOME INACTIVATION;

ADULT; BASE SEQUENCE; BEHCET SYNDROME; CHILD; FEMALE; HETEROZYGOTE; HUMANS; I-KAPPA B KINASE; MOLECULAR SEQUENCE DATA; MUTATION; X CHROMOSOME INACTIVATION;

EID: 78149265597     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01432.x     Document Type: Article

References (25)

1. Yamaoka S, Courtois G, Bessia C et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 1998: 93: 1231-1240.
2. Smahi A, Courtois G, Vabres P et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 2000: 405: 466-472.
3. Zonana J, Elder ME, Schneider LC et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet 2000: 67: 1555-1562.
4. Chajek T, Fainaru M. Behçet's disease. Report of 41 cases and a review of the literature. Medicine 1975: 54: 179-196.
5. Koné-Paut I, Yurdakul S, Bahabri SA et al. Clinical features of Behçet's disease in children: an international collaborative study of 86 cases. J Pediatr 1998: 132: 721-725.
6. The Behçet's Disease Research Committee of Japan. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease: a multicenter study. J Rheumatol 1989: 16: 506-511.
7. Takada H, Yoshikawa H, Imaizumi M et al. Delayed separation of the umbilical cord in two siblings with Interleukin-1 receptor-associated kinase 4 deficiency: rapid screening by flow cytometer. J Pediatr 2006: 148: 546-548.
8. Takada H, Kanegane H, Nomura A et al. Female agammaglobulinemia due to the Bruton tyrosine kinase deficiency caused by extremely skewed X-chromosome inactivation. Blood 2004: 103: 185-187.
9. Dündar SV, Gençalp U, Simşek H. Familial cases of Behçet's disease. Br J Dermatol 1985: 113: 319-321.
10. Akpolat T, Koc Y, Yeniay I et al. Familial Behçet's disease. Eur J Med 1992: 1: 391-395.
11. Nishiura K, Kotake S, Ichiishi A et al. Familial occurrence of Behçet's disease. Jpn J Ophthalmol 1996: 40: 255-259.
12. Kone-Paut I, Geisler I, Wechsler B et al. Familial aggregation in Behçet's disease: high frequency in siblings and parents of pediatric probands. J Pediatr 1999: 135: 89-93.
13. Gül A, Inanç M, Ocal L et al. Familial aggregation of Behçet's disease in Turkey. Ann Rheum Dis 2000: 59: 622-625.
14. Fietta P. Behçet's disease: familial clustering and immunogenetics. Clin Exp Rheumatol 2005: 23: S96-S105.
15. Touitou I, Magne X, Molinari N et al. MEFV mutations in Behçet's disease. Hum Mutat 2000: 16: 271-272.
16. Ammann AJ, Johnson A, Fyfe GA et al. Behçet syndrome. J Pediatr 1985: 107: 41-43.
17. Menni S, Piccinno R, Biolchini A et al. Incontinentia pigmenti and Behcet's syndrome: an unusual combination. Acta Derm Venereol 1986: 66: 351-354.
18. Endoh M, Yokozeki H, Maruyama R et al. Incontinentia pigmenti and Behçet's disease: a case of impaired neutrophil chemotaxis. Dermatology 1996: 192: 285-287.
19. Berlin AL, Paller AS, Chan LS. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology. J Am Acad Dermatol 2002: 47: 169-187.
20. Nelson DL. NEMO, NFkappaB signaling and incontinentia pigmenti. Curr Opin Genet Dev 2006: 16: 282-288.
21. Jain A, Ma CA, Liu S et al. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2001: 2: 223-228.
22. Carter RS, Pennington KN, Ungurait BJ et al. In vivo identification of inducible phosphoacceptors in the IKKγ/NEMO subunit of human IκB kinase. J Biol Chem 2003; 278: 19642-19648.
23. Cordier F, Grubisha O, Traincard F et al. The zinc finger of NEMO is a functional ubiquitin-binding domain. J Biol Chem 2009: 284: 2902-2907.
24. Shifera AS, Horwits M. Mutations in the zinc finger domain of IKKγ block the activation of NF-κB and the induction of IL-2 in stimulated T lymphocytes. Mol Immunol 2008: 45: 1633-1645.
25. Nenci A, Becker C, Wullaert A et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007: 446: 557-561.